Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Patient #19

<< Previous

Bullboard Posts

Next >>

Comment by Pandoraon Oct 03, 2021 1:22pm

371 Views

Post# 33958821

RE:RE:RE:RE:RE:RE:Patient #19

enriquesuave wrote: Yes by August 30th they had treated a total of 24 patients, so between about November 20- Dec-7 patients 21-24 should be seen for their 90 day assessment. My guess is in 2-3 weeks we should get Quarterly and data on #19, and 20. Hopefully we get COVID-19 update as well.

Any guesses on action to be taken re the 37.5 cent warrants expiring in November. Will they be allowed to expire or will the date be extended?

<< Previous

Bullboard Posts

Next >>

AI companies to invest in